Sun Pharma Industries witnessed heavy buying interest as the stock rallied 8.1% on massive volume. The Company’s Halol plant is reported to have received a voluntary action initiated status which requires no re-inspection at the facility. It is currently consolidating in a first-stage base pattern with pivot price of Rs 608.95.
